Efficacy, Tolerability, and Cost of Iron Polymaltose vs Ferrous Sulphate in Pregnancy

The WHO defines anemia in pregnancy as hemoglobin < 11 g/dL, with iron deficiency anemia (IDA) being the most common type. While oral iron supplementation generally treats IDA effectively, side effects often reduce compliance. This study evaluates the efficacy, safety, cost, and compliance of iron polymaltose complex (IPC) compared to ferrous sulphate in pregnant women.